Esmée J. van Vliet

Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids

Johanna F. Dekkers, Esmée J. van Vliet, Norman Sachs et al. · Nature Protocols · 2021 · 265 citations · Full text

Medicine, Cancer Biology, Oncology +15

Uncovering the mode of action of engineered T cells in patient cancer organoids

Johanna F. Dekkers, María Alieva, Astrid Cleven et al. · Nature Biotechnology · 2022 · 212 citations · Full text

Life Sciences, Immunology, Oncology +17

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 158 citations

Medicine, Endocrinology, Pharmacology +14

Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy

Gabriele Picco, Chiara M. Cattaneo, Esmée J. van Vliet et al. · Cancer Discovery · 2021 · 114 citations · Full text

Medicine, Cancer Biology, Oncology +17

Revealing the spatio-phenotypic patterning of cells in healthy and tumor tissues with mLSR-3D and STAPL-3D

Ravian L. van Ineveld, Michiel Kleinnijenhuis, María Alieva et al. · Nature Biotechnology · 2021 · 33 citations · Full text

Life Sciences, Cell Biology, Oncology +14